cp wire

CP Wire Articles

Amicus Therapeutics Ramps Up Gene Therapy Portfolio with Acquisition of 10 Programs
  • Amicus will make an upfront cash payment of $100 million
  • The company also announced closing a $150 million term loan to help finance the acquisition and development costs
  • ... read more
Thu, 09/20/18 - 09:31 am
Pfizer's Pneumococcal Conjugate Vaccine Awarded Breakthrough Therapy Designation
  • The vaccine was awarded fast-track status by the FDA in October of 2017
  • Pfizer expects to start Phase 3 trials in a few months


Pfizer Inc. (NYSE:PFE) announced on 9/... read more

Thu, 09/20/18 - 09:08 am
MaaT Pharma Presents Analysis of Its First-in-Class High Diversity Microbiome Therapeutic

MaaT Pharma announced on 9/18/19 the presentation of the analysis of MaaT Pharma’s lead biotherapeutic, MaaT013, demonstrating its drug product characteristics using MaaT Pharma’s proprietary big... read more

Wed, 09/19/18 - 10:57 pm
Argenx To Raise $300 million in U.S. public offering
  • argynx has 8 drugs in development
  • Partners include Abbvie, LEO Pharma, and Staten Biotech

argenx (Euronext & Nasdaq: ARGX) a clinical-stage biotechnology company... read more

Wed, 09/19/18 - 09:32 am
Canada Approves Cabometyx for Adults with Previously Treated Advanced Renal Cell Carcinoma
  • Cabometyx has orphan drug status in the US
  • Takeda has rights to all indications for Cabometyx in Japan


Exelixis, Inc.  (NASDAQ:EXEL) announced on 9/19/18 that its... read more

Wed, 09/19/18 - 09:16 am

Pages